Non adherence to inhalational medications and associated factors among patients with asthma in a referral hospital in Ethiopia, using validated tool TAI

Asthma Research and Practice 2017 3:7
 

https://doi.org/10.1186/s40733-017-0035-0

Abstract

Background

Asthma is a chronic inflammatory condition of the airways that affects roughly 358 million people globally. It is a serious global health problem with an increasing prevalence worldwide. Most people affected are in low- and middle-income countries including Ethiopia. The association between non -adherence and poor disease control is clearly stated in different literatures. The main objective of the present study was to assess self-reported non- adherence level and to identify the potential factors associated with non-adherence.

Methods

An institution based cross-sectional study was conducted in university of Gondar teaching and referral hospital. The data was collected using a validated tool called Test of Adherence to Inhalers (TAI).

Result

Among the total of study participants, higher proportions of patients were female (57.3%). Large number of the respondents (59.1%) were Unable to read and write. 18.3% of inhalational user asthmatic patients were not adherent to inhalational medications. According to this study only 49.4% of the respondents were adherent to inhalations and 32.3% of them were intermediate adherent to inhalational anti asthmatics medications. Lack of education about the Proper use of inhalational anti-asthmatics medications, poly pharmacy and co-morbidities were statistically significant factors associated with non-adherence.

Conclusion

The rate of non-adherence to inhalational anti asthmatics is high. Therefore, promoting optimal medication adherences through education, proper patient consultation is essential to optimize the benefits of treatment. Measurement of the degree of non-adherence to inhaled treatment in each individual patient is important in early interventional practice.

Download PDF

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @worldallergy: The AAAAI/WAO Joint Congress is only 1 week away. Be sure to follow #AAAAIWAO18 to hear about all the latest research in…
2hreplyretweetfavorite
Interasma RT @Aller_MD: Study: Researchers Retrained Immune Systems of Mice to Switch Off Anaphylaxis https://t.co/NEjS1hZxDt https://t.co/GixFWhWvoC
3hreplyretweetfavorite
Interasma RT @Aller_MD: Integration of eHealth Tools in the Process of Workplace Health Promotion: Proposal for Design and Implementation https://t.c…
3hreplyretweetfavorite
Interasma RT @Aller_MD: Aimmune's Peanut Allergy Drug Meets Main Goal, Shares Surge https://t.co/cSVVr9Cm48 https://t.co/OQZVlq8Wfx
3hreplyretweetfavorite
Interasma RT @Aller_MD: Top story: EUFOREA on Twitter: "The EU summit 2018 on #mhealth, air pollution &… https://t.co/yZWlx0YgdD, see more https://t.…
3hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma